Patents by Inventor Conor Scully

Conor Scully has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CYCLIC APELIN RECEPTOR AGONISTS
    Publication number: 20230382950
    Abstract: The disclosures herein relate to novel compounds of formula (1) and salts thereof, wherein Q, X, AA1, AA2, AA3, AA4, AA5, AA6, AA7, AA8, R1, R2 and n are defined herein, and their use in treating, preventing, ameliorating, controlling or reducing the risk of disorders associated with apelin receptors.
    Type: Application
    Filed: October 12, 2021
    Publication date: November 30, 2023
    Applicant: HEPTARES THERAPEUTICS LIMITED
    Inventors: Giles Albert BROWN, Miles Stuart CONGREVE, Conor SCULLY, Rebecca PAUL
  • LINEAR APELIN RECEPTOR AGONISTS
    Publication number: 20230382949
    Abstract: The disclosures herein relate to novel compounds of formula (1): and salts thereof, wherein Q, X, AA1, AA2, AA3, AA4, AA5, AA6, AA7, AA8, AA9, AA10, AA11, AA12, AA13, R1 R2 and n are defined herein, and their use in treating, preventing, ameliorating, controlling or reducing the risk of disorders associated with Apelin receptors.
    Type: Application
    Filed: October 12, 2021
    Publication date: November 30, 2023
    Applicant: HEPTARES THERAPEUTICS LIMITED
    Inventors: Giles Albert BROWN, Miles Stuart CONGREVE, Conor SCULLY, Rebecca PAUL
  • GLP RECEPTOR AGONISTS
    Publication number: 20230295260
    Abstract: The disclosures herein relate to novel compounds of formula (1): and salts thereof, wherein Q, W, X, Y, Z, AA1, AA2, AA3, AA4, AA5, AA6, AA7, AA8, AA9, LysR, R 1, R2 and n are defined herein, and their use in treating, preventing, ameliorating, controlling or reducing the risk of disorders associated with Glucagon-like peptide (GLP) receptors.
    Type: Application
    Filed: March 16, 2021
    Publication date: September 21, 2023
    Applicant: HEPTARES THERAPEUTICS LIMITED
    Inventors: Giles Albert BROWN, Miles Stuart CONGREVE, Conor SCULLY, Rebecca PAUL, Andrea BORTOLATO
  • GLP-1 RECEPTOR ANTAGONISTS
    Publication number: 20230279053
    Abstract: The disclosures herein relate to novel internally cyclic peptide compounds of formula (1) and salts thereof, wherein R1, AA1, AA2, LysR, X and Y are defined herein, and their use in treating, preventing, ameliorating, controlling or reducing the risk of disorders associated with Glucagon-like peptide-1 (GLP-1) receptors.
    Type: Application
    Filed: July 27, 2021
    Publication date: September 7, 2023
    Applicant: HEPTARES THERAPEUTICS LIMITED
    Inventors: Giles Albert BROWN, Miles Stuart CONGREVE, Conor SCULLY
  • CYCLOHEXAPEPTIDES AS SELECTIVE SOMATOSTATIN SST5 RECEPTOR AGONISTS
    Publication number: 20210363188
    Abstract: The disclosures herein relate to novel compounds of formula (1): (1) and salts thereof, wherein W, X, Y, Z, m, n, q, R1, R2, R3, R4, R5 and R6 are defined herein, and their use in treating, preventing, ameliorating, controlling or reducing the risk of disorders associated with somatostatin receptors.
    Type: Application
    Filed: October 14, 2019
    Publication date: November 25, 2021
    Inventors: Giles Albert Brown, Miles Stuart Congreve, Conor Scully, Rebecca Paul, Andrea Bortolato
  • GLP-1 RECEPTOR ANTAGONISTS
    Publication number: 20210355186
    Abstract: The disclosures herein relate to novel compounds of formula (1): and salts thereof, wherein R1, AA1, AA2, LysR, X and Y are defined herein, and their use in treating, preventing, ameliorating, controlling or reducing the risk of disorders associated with Glucagon-like peptide-1 (GLP-1) receptors.
    Type: Application
    Filed: October 14, 2019
    Publication date: November 18, 2021
    Inventors: Giles Albert Brown, Miles Stuart Congreve, Conor Scully